GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (LTS:0A0D) » Definitions » EV-to-FCF

Alcon (LTS:0A0D) EV-to-FCF : 74.70 (As of Dec. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Alcon EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alcon's Enterprise Value is CHF40,520 Mil. Alcon's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was CHF542 Mil. Therefore, Alcon's EV-to-FCF for today is 74.70.

The historical rank and industry rank for Alcon's EV-to-FCF or its related term are showing as below:

LTS:0A0D' s EV-to-FCF Range Over the Past 10 Years
Min: -292.42   Med: 133.73   Max: 829.7
Current: 75.87

During the past 8 years, the highest EV-to-FCF of Alcon was 829.70. The lowest was -292.42. And the median was 133.73.

LTS:0A0D's EV-to-FCF is ranked worse than
81.55% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.735 vs LTS:0A0D: 75.87

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Alcon's stock price is CHF76.50. Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was CHF2.039. Therefore, Alcon's PE Ratio (TTM) for today is 37.52.


Alcon EV-to-FCF Historical Data

The historical data trend for Alcon's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon EV-to-FCF Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial 123.69 138.00 277.97 79.08 77.23

Alcon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.00 77.23 151.27 79.28 74.44

Competitive Comparison of Alcon's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Alcon's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcon's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Alcon's EV-to-FCF falls into.



Alcon EV-to-FCF Calculation

Alcon's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=40519.644/542.401
=74.70

Alcon's current Enterprise Value is CHF40,520 Mil.
Alcon's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF542 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alcon  (LTS:0A0D) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Alcon's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=76.50/2.039
=37.52

Alcon's share price for today is CHF76.50.
Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.039.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Alcon EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Alcon's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon Business Description

Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Alcon Headlines

No Headlines